Case descriptions

Importance of Immunogenicity Investigations in Clinical Development of Therapeutic Proteins

User Rating: 0 / 5

Star InactiveStar InactiveStar InactiveStar InactiveStar Inactive
 

Ando spoke about the Importance of Immunogenicity Investigations in Clinical Development of Therapeutic Proteins at a workshop organized by Xendo GmbH, a ProPharma Group company, in collaboration with the biotech syndicate Berlin-Brandenburg bbb.

ando-logo-01.png

Nordre Strandvej 119D,
3150, Hellebaek, Denmark
+45 2568 3668
anke.domdey@andobio.com

Search